Michael Chen

Great Bay Bio Holdings Ltd. is a high-tech enterprise based in China that specializes in applying artificial intelligence and other cutting-edge technologies in CMC bioprocessing. The Chinese company aims to solve numerous pain-points of the biopharmaceutical industry, including high failure rates, long development timelines, and high costs. Great Bay Bio has accumulated massive bioprocessing development data from its 3100 m2 CMC facility and has successfully brought a number of biologic products to NDA stage. The company has created an intelligent centralized database where deep learning is being performed to create a next-generation, all-encompassing AI-enabled bioprocessing ecosystem. Great Bay Bio is headquartered in China and was founded in 2019 by Kingsley Leung and Michael Chen, who has been the CEO since incorporation.